New findings on autoimmune etiology of idiopathic granulomatous mastitis: serum IL-17, IL-22 and IL-23 levels of patients M Saydam, KB Yilmaz, M Sahin, H Yanik, M Akinci, I Yilmaz, S Balas, ... Journal of Investigative Surgery 34 (9), 993-997, 2021 | 53 | 2021 |
Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer M Karpuz, M Silindir-Gunay, AY Ozer, SC Ozturk, H Yanik, M Tuncel, ... European Journal of Pharmaceutical Sciences 156, 105576, 2021 | 43 | 2021 |
Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer E Tavukcuoglu, U Horzum, H Yanik, A Uner, D Yoyen‐Ermis, SK Nural, ... European journal of immunology 50 (12), 2067-2074, 2020 | 31 | 2020 |
Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors S Anthiya, SC Öztürk, H Yanik, E Tavukcuoglu, A Şahin, D Datta, ... Journal of Controlled Release 357, 67-83, 2023 | 30 | 2023 |
Breast cancer cells and macrophages in a paracrine-juxtacrine loop S Onal, M Turker-Burhan, G Bati-Ayaz, H Yanik, D Pesen-Okvur Biomaterials 267, 120412, 2021 | 23 | 2021 |
Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model S Ünal, SC Öztürk, E Bilgiç, H Yanık, P Korkusuz, Y Aktaş, JM Benito, ... European Journal of Pharmaceutics and Biopharmaceutics 169, 168-177, 2021 | 18 | 2021 |
Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes MA Kursunel, EZ Taskiran, E Tavukcuoglu, H Yanik, F Demirag, ... Cancer Immunology, Immunotherapy, 1-15, 2022 | 17 | 2022 |
Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier I Seko, H Tonbul, E Tavukçuoğlu, A Şahin, S Akbas, H Yanık, SC Öztürk, ... Journal of Drug Delivery Science and Technology 66, 102867, 2021 | 16 | 2021 |
A positive feedback loop driven by fibronectin and IL-1β sustains the inflammatory microenvironment in breast cancer G Tunali, H Yanik, SC Ozturk, S Demirkol-Canli, G Efthymiou, KB Yilmaz, ... Breast Cancer Research 25 (1), 27, 2023 | 6 | 2023 |
Effector Th1 cells under PD‐1 and CTLA‐4 checkpoint blockade abrogate the upregulation of multiple inhibitory receptors and by‐pass exhaustion U Horzum, H Yanik, EZ Taskiran, G Esendagli Immunology 167 (4), 640-650, 2022 | 4 | 2022 |
Memory T cell responses in seronegative older adults following SARS-CoV-2 vaccination M Hafızoğlu, AO Bas, E Tavukçuoğlu, Z Sahiner, MG Oytun, S Ulutürk, ... Clinical Immunology Communications 2, 154-158, 2022 | 1 | 2022 |
Effects of transcutaneous electrical nerve stimulation on rats with post-operative ileus Ş Balas, KB Yılmaz, S Tokgöz, M Saydam, H Yanık, E Önder, M Akıncı, ... Turkish Journal of Trauma & Emergency Surgery 28 (10), 1382, 2022 | 1 | 2022 |
Serum endocan levels can predict malignancy of thyroid: a prospective clinical study M Şahin, M Saydam, K Yılmaz, H Yanık, İ Yılmaz, G Gündoğan, C Azılı, ... Anadolu Güncel Tıp Dergisi 2 (4), 117-122, 2020 | 1 | 2020 |
Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination E Tavukcuoglu, H Yanik, M Parveen, S Uluturk, M Durusu-Tanriover, ... Scientific Reports 13 (1), 4610, 2023 | | 2023 |
Clinical Immunology Communications M Hafızoğlu, AO Bas, E Tavukçuoğlu, Z Sahiner, MG Oytun, S Ulutürk, ... Clinical Immunology 2, 154-158, 2022 | | 2022 |
Cytotoxicity and Biological Compatibility E Tavukcuoglu, H Yanik, G Esendagli Drug Delivery with Targeted Nanoparticles, 223-246, 2021 | | 2021 |
Design and synthesis of novel peptidomimetics for cancer immunotherapy C Kose, E Uysal, B Yazici, Z Tugay, SI Dingis-Birgul, H Yanik, ... | | 2020 |